Patient groups must reveal corporate sponsorship, urges campaign groupBMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c4459 (Published 16 August 2010) Cite this as: BMJ 2010;341:c4459
- Tony Sheldon
An international pharmaceutical campaign group is urging the European Medicines Agency to tighten its rules that require patient and consumer bodies that work with the agency to disclose any corporate funding they receive. This follows the group’s research findings that two thirds of the bodies advising the agency received “partial or significant” funding from pharmaceutical manufacturers or industry associations.
At the same time, fewer than half of these bodies met the agency’s own financial reporting guidelines, the report by Health Action International Europe shows.
The campaign group investigated the funding and disclosure of 23 organisations that were eligible to work …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial